Φορτώνει......
Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson’s disease
BACKGROUND: Inhaled levodopa may quickly resolve off periods in Parkinson’s disease. Our aim was to determine the pharmacokinetics and tolerability of a new levodopa dry-powder inhaler. METHODS: A single-centre, single-ascending, single-dose–response study was performed. Over three visits, eight Par...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Chronic Dis |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589987/ https://ncbi.nlm.nih.gov/pubmed/31258882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319857617 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|